These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12787013)

  • 1. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
    Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
    Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
    Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
    Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study.
    Carton E; Blas AM; Perret C; Le Bihan M
    Support Care Cancer; 2024 Jun; 32(7):410. PubMed ID: 38839667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
    Heibloem RE; Komen MMC; Ilozumba OUC; van den Hurk CJG
    Support Care Cancer; 2023 Apr; 31(5):273. PubMed ID: 37067605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
    Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
    Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
    Ridderheim M; Bjurberg M; Gustavsson A
    Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
    Betticher DC; Delmore G; Breitenstein U; Anchisi S; Zimmerli-Schwab B; Müller A; von Moos R; Hügli-Dayer AM; Schefer H; Bodenmann S; Bühler V; Trueb RR
    Support Care Cancer; 2013 Sep; 21(9):2565-73. PubMed ID: 23636645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.
    Katsimbri P; Bamias A; Pavlidis N
    Eur J Cancer; 2000 Apr; 36(6):766-71. PubMed ID: 10762750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
    Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres.
    Chan J; Adderley H; Alameddine M; Armstrong A; Arundell D; Fox R; Harries M; Lim J; Salih Z; Tetlow C; Wong H; Thorp N
    Eur J Cancer Care (Engl); 2021 May; 30(3):e13395. PubMed ID: 33350015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
    Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
    Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
    Villarreal-Garza C; Mesa-Chavez F; Garza-Ledezma MRA; Peña-Curiel O; Martinez-Cannon BA; Canavati-Marcos M; Cardona-Huerta S
    Breast Cancer Res Treat; 2021 Jan; 185(2):453-458. PubMed ID: 33125621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.